Asthma medicine approval is a local success story – Philadelphia Business Journal


Philadelphia Business Journal

Asthma medicine approval is a local success story
Philadelphia Business Journal
… Reporter Philadelphia Business Journal. Stephen Tullman, managing partner of NeXeption. Enlarge. Stephen Tullman, managing partner of NeXeption. Jeff Fusco. FDA approval for the asthma drug Cinqair illustrates the benefits of one deal that got done.

View full post on asthma – Google News

What leads to weight loss success in adults with asthma? – EurekAlert (press release)

What leads to weight loss success in adults with asthma?
EurekAlert (press release)
Among overweight and obese adults who had asthma and participated in weight loss programs, more severe asthma, male sex, and improvements in eating behaviors were all linked with better success at losing weight. The finding that individuals with more …

and more »

View full post on asthma – Google News

Array BioPharma scores midstage success for asthma drug – FierceBiotech

Array BioPharma scores midstage success for asthma drug
FierceBiotech
Array BioPharma has another asset on deck for a potential partnership. The Boulder, CO-based drug developer has touted upbeat Phase II data for an experimental drug in patients with allergic asthma, and the company ($ARRY) plans to seek a partner to 
Array asthma drug meets main goal in mid-stage studyReuters
Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung Wall Street Journal
Array Seeks Asthma Drug Partner Following Mid-Stage Study ResultsTheStreet.com
RTT News –Benzinga –Yahoo! News
all 8 news articles »

View full post on asthma – Google News

Success Story: Childbirth, asthma prompted Wendy Fleming to get serious about … – Memphis Commercial Appeal

Success Story: Childbirth, asthma prompted Wendy Fleming to get serious about
Memphis Commercial Appeal
BEFORE: Wendy Fleming "piled on the weight" after she had her first baby and was diagnosed with asthma at age 37. She began meeting with personal trainer Yvette Smith three days a week, taking Smith's fitness classes, and cutting back on her fat intake

View full post on asthma – Google News

Phase III Success for Boehringer Ingelheim Asthma Drug – Genetic Engineering News

Phase III Success for Boehringer Ingelheim Asthma Drug
Genetic Engineering News
Boehringer-Ingelheim said today its once-daily asthma drug tiotropium, delivered via Respimat® Soft Mist™ Inhaler, produced favorable Phase III results by increasing the time to first severe exacerbation, and time to first episode of asthma worsening
Boehringer Ingelheim's tiotropium shows promising results in patients with News-Medical.net
Phase III results: tiotropium* Respimat® effective in symptomatic asthma EON: Enhanced Online News (press release)
Boehringer Ingelheim reports positive data from symptomatic asthma trialsZenopa

all 5 news articles »

View full post on asthma – Google News